The spectrum and changes of biopsy-proven kidney diseases in Chinese children

被引:6
|
作者
He, Guohua [1 ]
Tao, Liyuan [2 ]
Li, Chenglong [3 ]
Zhong, Xuhui [1 ]
Wang, Haibo [4 ]
Ding, Jie [1 ]
机构
[1] Peking Univ First Hosp, Dept Pediat, Beijing, Peoples R China
[2] Peking Univ Third Hosp, Res Ctr Clin Epidemiol, Beijing, Peoples R China
[3] Peking Univ, Peking Univ First Hosp, Clin Res Inst, Beijing, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Clin Trial Unit, Guangzhou, Peoples R China
基金
中央高校基本科研业务费专项资金资助; 北京市自然科学基金;
关键词
Children; Biopsy; Pathology; SINGLE-CENTER EXPERIENCE; RENAL BIOPSY; GLOMERULAR-DISEASES; MORTALITY;
D O I
10.1007/s40620-022-01527-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim The study aimed to investigate the spectrum of biopsy-proven kidney disease in Chinese children. Methods Records of children 0-17 years old who underwent native kidney biopsy from June 1st, 2013 to December 31st, 2018 in the national inpatients' database of China were analyzed. Biopsy-proven kidney diseases of different sex, age groups, and diagnosis, and the changing patterns of kidney disease compared with the previous study were analyzed. Results A total of 21,311 patients from 232 hospitals with a median age of 11.34 years were included. Immunoglobulin A vasculitis with nephritis (IgAVN) was the most common pathological finding [29.17%, 95% confidence interval (confidence interval, CI) = 28.56-29.78], followed by IgA nephropathy (IgAN) (22.70%, 95% CI = 22.14-23.27). IgAN was the most common finding in patients with hematuria (60.75%, 95% CI = 58.83-62.65], proteinuria (33.43%, 95% CI = 30.54-36.42), and hematuria plus proteinuria (62.77%, 95% CI = 56.19-69.02). Minimal change disease was the most common finding (40.69%, 95% CI = 39.41-41.98) in nephrotic syndrome. The proportion of IgAVN in patients with biopsy-proven glomerular disease increased year by year during 2013-2018 (p for trend < 0.001) and was higher than that of 2004-2014 [29.41% (95% CI = 29.10-29.72) in 2013-2018 vs. 13.35% (95% CI = 12.97-13.73) 2004-2014, p < 0.001]. The proportion of hepatitis B virus associated nephritis during 2013-2018 was lower than that of 2004-2014 [0.44% (95% CI = 0.36-0.54) in 2013-2018 vs. 0.87% (95% CI = 0.67-1.10) in 2004-2014, p < 0.001]. Conclusions IgAVN and IgAN were the most common types of pathological findings in children who underwent kidney biopsies from 2013 to 2018. The pathological spectrum of kidney biopsy changed over time.
引用
收藏
页码:417 / 427
页数:11
相关论文
共 50 条
  • [1] The spectrum and changes of biopsy-proven kidney diseases in Chinese children
    Guohua He
    Liyuan Tao
    Chenglong Li
    Xuhui Zhong
    Haibo Wang
    Jie Ding
    Journal of Nephrology, 2023, 36 : 417 - 427
  • [2] The spectrum of biopsy-proven kidney diseases in elderly Chinese patients
    Jin, Bo
    Zeng, Caihong
    Ge, Yongchun
    Le, Weibo
    Xie, Honglang
    Chen, Hao
    Liang, Shaoshan
    Xu, Feng
    Jiang, Song
    Liu, Zhihong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (12) : 2251 - 2259
  • [3] Spectrum of biopsy-proven kidney diseases in northwest China: a review of 30 years of experiences
    Li, Huixian
    Yu, Xiaoyang
    Lan, Ping
    Wang, Zhigang
    Yang, Shifeng
    Feng, Jie
    Hao, Dapeng
    Niu, Dan
    Hao, Yaning
    Sun, Jiping
    Zhang, Yali
    Lv, Jing
    Yin, Aiping
    Xie, Liyi
    Lu, Wanhong
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (10) : 2609 - 2616
  • [4] The spectrum of biopsy-proven renal diseases in Korea
    Lim, Beom Jin
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2020, 39 (01) : 1 - 3
  • [5] Epidemiology of biopsy-proven glomerular diseases in Chinese children: A scoping review
    Li Yetong
    Yang Yue
    Zhuo Li
    Wu Dan
    Li Wenge
    Liu Xiaorong
    慢性疾病与转化医学(英文), 2022, 08 (04) : 271 - 280
  • [6] Changes in spectrum of biopsy-proven kidney diseases within decade: an analysis based on 10 199 cases from South China
    Chen, Xiao-jun
    Huang, Yao
    Yuan, Shuguang
    Han, Yachun
    Li, Zheng
    Xu, Xiangqing
    Fu, Xiao
    Peng, Fenghua
    Zhang, Sanyong
    Xiang, Liuxia
    Shi, Kewen
    Cui, Xinyuan
    Zhang, Zurong
    Wei, Jinying
    Xia, Shiyu
    Xiao, Yang
    Sun, Lin
    Liu, Hong
    Zhu, Xuejing
    POSTGRADUATE MEDICAL JOURNAL, 2024, 100 (1179) : 20 - 27
  • [7] Spectrum of biopsy-proven kidney diseases in northwest China: a review of 30 years of experiences
    Huixian Li
    Xiaoyang Yu
    Ping Lan
    Zhigang Wang
    Shifeng Yang
    Jie Feng
    Dapeng Hao
    Dan Niu
    Yaning Hao
    Jiping Sun
    Yali Zhang
    Jing Lv
    Aiping Yin
    Liyi Xie
    Wanhong Lu
    International Urology and Nephrology, 2022, 54 : 2609 - 2616
  • [8] Spectrum and Distribution of Biopsy-proven Kidney Diseases: A 12-year Survey of a Single Center in Iran
    Nili, Fatemeh
    Farahani, Elham
    Moghimian, Mehran
    Jahanzad, Issa
    Minoo, Farzaneh-Sadat
    Salarvand, Samaneh
    Abdollahi, Alireza
    Mirshahvalad, Seyed Ali
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2023, 34 (04) : 346 - 354
  • [9] Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China
    Hou, Jin-Hua
    Zhu, Hui-Xian
    Zhou, Min-Lin
    Le, Wei-Bo
    Zeng, Cai-Hong
    Liang, Shao-Shan
    Xu, Feng
    Liang, Dan-Dan
    Shao, Si-Jia
    Liu, Ye
    Liu, Zhi-Hong
    KIDNEY DISEASES, 2018, 4 (01) : 10 - 19
  • [10] Biopsy-proven kidney diseases in the elderly: clinical characteristics, renal histopathological spectrum and prognostic factors
    Chen, Yue
    Li, Ping
    Cui, Chunli
    Yuan, Aihong
    Zhang, Kun
    Yu, Chen
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2016, 44 (05) : 1092 - 1102